Molecular Pathogenesis of CLL: Genomics and Proteomics
Molecular Pathogenensis of CLL: Microenvironment and Signaling
Clonal Dynamics, Competition, and Disease Evolution
Theme 2
Approach Considerations and Treatment Options in CLL
Prognostication and Prediction in the Era of Novel Drugs
Industry Supported Symposium
Minimal Residual Disease: Methods and Clinical Application
Industry Supported Symposium
Frontline Therapy for CLL
Keynote
Treatment of Relapsed/Refractory CLL
Industry Supported Symposium
Theme 3
Rationally Designed Therapy on the Horizon in CLL
New Agents in CLL Clinical Trials
Immunotherapy for CLL
Supportive Care and Consequences of Immune Dysregulation in CLL
iwCLL Updates